Based on these data, it is proposed that RG6016 may modulate the HIF-1α pathway via LSD1, UCHL1, and MYC in aggressive cancers such as SCLC, thereby influencing key processes like hypoxia response, metastasis, and neuroendocrine differentiation. Here, KDM1A is linked to small cell lung carcinoma.